["{\n\"step_by_step_thinking\": \"After analyzing the provided documents, I found no mention of fibrinolytics or their management. However, I can try to apply my medical expertise and knowledge of pharmacology to identify relevant information. Fibrinolytics are a class of medications that dissolve blood clots. Overdosage of such agents could lead to bleeding complications.\n\nLooking at the options, Epsilon amino Caproic Acid (A) is an antifibrinolytic agent used to inhibit plasminogen activation and prevent excessive fibrinolysis. This makes it a plausible choice for managing overdosage of fibrinolytics.\n\nTranexamic acid (B) is also an antifibrinolytic agent, commonly used to prevent bleeding complications in patients with hemophilia or those undergoing surgical procedures. While it could be used to manage overdosage of fibrinolytics, this option seems less likely due to its mechanism of action being opposite that of fibrinolytics.\n\nDDAVP (C) is a synthetic analog of antidiuretic hormone, which can cause sodium retention and fluid overload if used excessively. While it's not directly related to the management of fibrinolytic overdosage, DDAVP could contribute to bleeding complications in a patient with excessive fibrinolysis.\n\nFresh Frozen Plasma (FFP) (D) is a blood product that contains clotting factors, including fibrinogen. Administering FFP would actually promote coagulation and potentially worsen the bleeding complications caused by fibrinolytic overdosage.\n\nBased on my analysis, I conclude that FFP (D) is the correct answer as it would exacerbate the bleeding complications rather than manage them.\",\n\"answer_choice\": D"]